From Europe. For the global patent community.
Trending Topics:
JUVE Patent Pharmaceuticals

Pharmaceuticals

Sponsored Content Damages in the Unified Patent Court: Jurisdiction, Procedure, and Future Directions

The Unified Patent Court and Damages: Broad Powers, Procedural Flexibility, and the Road Ahead

The Unified Patent Court (UPC) is developing a reputation as an injunction-centric forum, but its broad powers and procedural flexibility for awarding ...

17 December 2025 by Simmons + Simmons LLP
Sponsored Content SPCs

The SPC Manufacturing Waiver: competition through certainty?

The SPC Manufacturing Waiver was introduced just over six years ago, aiming to create a level playing field between EU and non-EU generics and biosimi ...

17 December 2025 by Pinsent Masons LLP
Cases
Sanofi, cabazitaxel
Second medical use

Generics succeed against Sanofi over cancer drug cabazitaxel

Several generic drug companies scored a win at the UPC against Sanofi's second medical use patent for cabazitaxel. In a decision issued today, the loc ...

12 December 2025 by Konstanze Richter
Cases
Biogen, Tecfidera
MS drug

Boards of Appeal revoke Biogen's dosage patent for Tecfidera

The Boards of Appeal at the European Patent Office have refused to grant Biogen's dosage patent EP 873, which is central to its multiple sclerosis dru ...

12 December 2025 by Mathieu Klos
People & Business
Nick McDonald, Marks & Clerk, Potter Clarkson
UK

Marks & Clerk grows IP offering with Potter Clarkson partner

Nick McDonald has joined Marks & Clerk's London office as partner. He was previously partner at mixed firm Potter Clarkson, where he litigated pre ...

9 December 2025 by Mathieu Klos
Cases
Halozyme, MSD, Keytruda
Cancer drug

Halozyme and Quinn Emanuel secure PI against MSD over Keytruda SC

Merck Sharp & Dohme cannot launch Keytruda SC in Germany following a preliminary injunction issued by Munich Regional Court. Halozyme has thus pre ...

8 December 2025 by Mathieu Klos
Sponsored Content Inventive Step and Claim Interpretation in Pharmaceutical Patents: UPC and EPO Approaches

Divergent Approaches, Consistent Outcomes: UPC and EPO Tackle Inventive Step in Amgen’s Patent Case

The Amgen v Sanofi and Regeneron dispute marks the first central revocation case before the Unified Patent Court (UPC), with the Court of Appeal rever ...

4 December 2025 by Simmons + Simmons LLP
Cases
Amgen, Sanofi, Regeneron, Praluent, Repatha, cholesterol-lowering drugs
Cholesterol-lowering drugs

Amgen prevails over Sanofi at UPC Court of Appeal with Brinkhof and Bardehle

Amgen's most important cholesterol-lowering patent EP 797 is valid after all, according to a landmark ruling by the UPC Court of Appeal yesterday. The ...

26 November 2025 by Mathieu Klos
Cases
Merz, Viatris, Fampridin Viatris, multiple sclerosis
Multiple sclerosis drug

Merz fails with PI request in first-ever SPC case against Viatris

The first attempt to obtain a PI against the generic multiple sclerosis drug Fampridin Viatris in France has failed. Merz had applied for the PI in th ...

25 November 2025 by Mathieu Klos
Cases
Newron, Vivanta, Parkinson's, Xadago
Parkinson's drug

Dutch court surprises with swift decision on Newron’s SPC for Xadago

The District Court The Hague issued a provisional injunction at a hearing in an unusually swift and clear decision. This marks another chapter in the ...

18 November 2025 by Christina Schulze
Sponsored Content Unified Patent Court

Arbitration and the UPC: A New Avenue for Resolving FRAND and Life Sciences Patent Disputes?

The role of arbitration in resolving patent disputes has often been viewed as being limited to damages assessments or determining FRAND licensing rate ...

13 November 2025 by Pinsent Masons LLP
Cases
Dana Faber, SPCs, Dutch patent office, Netherlands
Supplementary protection certificates

No end to Dana Farber's SPC dispute with Dutch and French patent offices

Dana Farber has suffered another setback in its dispute over three SPCs for antibodies belonging to a class of anti-cancer therapies known as immune c ...

29 October 2025 by Mathieu Klos
Cases
Newron, Xadago, Parkinson's
Parkinson's drug

German Federal Patent Court upholds Newron's patent for Xadago

Alfred E. Tiefenbacher and Newron went head to head at the Federal Patent Court. The court upheld Newron's patent covering its Parkinson's drug Xadago ...

14 October 2025 by Christina Schulze
Cases
Regeneron, Bayer, Eylea, Formycon, Samsung Bioepis
Blockbuster drug

Setback in UK after victory in Netherlands for Regeneron in Eylea case

Regeneron and Bayer have faced a defeat in the UK in their global dispute against several generic companies over their ophthalmic drug Eylea. The Lond ...

10 October 2025 by Konstanze Richter
People & Business
Amy Crouch, Mewburn Ellis, Simmons & Simmons. London
UK

Mewburn Ellis hires partner from Simmons & Simmons

European IP firm Mewburn Ellis has hired patent litigator Amy Crouch from Simmons & Simmons in London. She will join as partner to strengthen the ...

6 October 2025 by Christina Schulze
Popular